Health care startups in Beijing, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Phil Rivers Technology | Beijing | Series A | $29.6M | 2026-08-05 |
| QL Biopharma | Beijing | Series C | $44.7M | 2026-09-14 |
| Infervision | Beijing | Series D | $140.0M | 2021-07-23 |
| Diyingjia Technology | Beijing | Series C | $3.0M | 2026-07-28 |
| Shukun Technology | Beijing | Series D | $105.8M | 2021-08-17 |
| Avistone Pharmaceuticals | Beijing | Series B | $140.7M | 2023-12-28 |
| Darwin Cell Biology | Beijing | Series C | $27.9M | 2025-12-08 |
| NeoCura | Beijing | Series A | $78.5M | 2021-12-21 |
8 rows of the CSV in 5 of its 18 columns.
- The 449 health care startups in Beijing, China have raised $11.3B in total.
- 49 of them closed their most recent round in the last 12 months, $572.3M combined.
- The largest of those rounds is Zhiran Medical's $89.6M Series B, dated September 2026.
- The most recent is Zhishu Technology's $30.0M Series C on 21 October 2026.
- Qiming Venture Partners is an investor in 7 of them, more than any other fund.
- Biotech is the most common other sector, with 100 companies (22%).
- 10% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (37% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
11 of 449| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 | 101 to 250 | 2018 |
| Leadinno Medical Valley | Leadinno Medical Valley produces medical devices that regulate neurological functions. | Health care | Series B | $29.7M | 2026-08-17 | $90.3M | Fortune Venture Capital, Cowin Capital, Taiyu Investment +2 | 10,001 or more | 2016 |
| Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| Diyingjia Technology | Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. | Artificial intelligence | Series C | $3.0M | 2026-07-28 | $32.3M | IDG Capital, Legend Capital, Microsoft Accelerator | 11 to 50 | 2017 |
| Yuewei Medical | Yuewei Medical develops interventional medical devices for cardiac surgery. | Health care | Series B | $14.3M | 2026-01-12 | $28.4M | IDG Capital, South China Venture Capital, Yuanhui Chuangyi +1 | 2019 | |
| Anlong Bio | Anlong Bio researches and develops nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. | Biotech | Series B | $14.3M | 2026-01-07 | $14.3M | TaiKun Fund | 51 to 100 | 2019 |
| Darwin Cell Biology | Darwin Cell Biology provides cell biotechnology services. | Biotech | Series C | $27.9M | 2025-12-08 | $62.4M | Shijingshan Modern Innovation Industry Fund, Shanghai Yungu Investment | 11 to 50 | 2016 |
| Cipher Gene Tech | Cipher Gene Tech operates a biomedical big data analysis and interpretation platform. | Health care | Series C | $13.8M | 2024-05-27 | Everest Venture Capital, Shenzhen Guozhong Venture Capital Management, Microsoft Accelerator +1 | 11 to 50 | 2015 | |
| Shukun Technology | Shukun Technology develops AI diagnostic systems for chronic diseases in China. | Artificial intelligence | Series D | $105.8M | 2021-08-17 | $296.4M | Qiming Venture Partners, Goldman Sachs, 5Y Capital +1 | 501 to 1,000 | 2017 |
| Infervision | Infervision uses deep learning and computer vision to help diagnose cancers. | Artificial intelligence | Series D | $140.0M | 2021-07-23 | $214.7M | Sequoia Capital, Qiming Venture Partners, CDH Investments +1 | 51 to 100 | 2015 |
| Keep Unicorn | Keep is a mobile fitness community offering training programs for different groups of people. | Education | Series F | $360.0M | 2021-01-10 | Goldman Sachs, Hillhouse Investment, Coatue +1 | 501 to 1,000 | 2014 |
Table 1. Health care startups in Beijing, China: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 449.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 | 101 to 250 | 2018 |
| 2 | Leadinno Medical Valley | Leadinno Medical Valley produces medical devices that regulate neurological functions. | Health care | Series B | $29.7M | 2026-08-17 | $90.3M | Fortune Venture Capital, Cowin Capital, Taiyu Investment +2 | 10,001 or more | 2016 |
| 3 | Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| 4 | Darwin Cell Biology | Darwin Cell Biology provides cell biotechnology services. | Biotech | Series C | $27.9M | 2025-12-08 | $62.4M | Shijingshan Modern Innovation Industry Fund, Shanghai Yungu Investment | 11 to 50 | 2016 |
| 5 | Yuewei Medical | Yuewei Medical develops interventional medical devices for cardiac surgery. | Health care | Series B | $14.3M | 2026-01-12 | $28.4M | IDG Capital, South China Venture Capital, Yuanhui Chuangyi +1 | 2019 | |
| 6 | Anlong Bio | Anlong Bio researches and develops nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. | Biotech | Series B | $14.3M | 2026-01-07 | $14.3M | TaiKun Fund | 51 to 100 | 2019 |
| 7 | Diyingjia Technology | Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. | Artificial intelligence | Series C | $3.0M | 2026-07-28 | $32.3M | IDG Capital, Legend Capital, Microsoft Accelerator | 11 to 50 | 2017 |
Table 2. Health care startups in Beijing, China: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 7 | 2% | ||
| 2 | IDG Capital | Private equity firm | Beijing, China | 7 | 2% | 2 | Diyingjia Technology, Yuewei Medical |
| 3 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 6 | 1% | ||
| 4 | ZhenFund | Entrepreneurship program | Beijing, China | 6 | 1% | ||
| 5 | Sinovation Ventures | Venture capital firm | Beijing, China | 6 | 1% | ||
| 6 | Matrix Partners China | Venture capital firm | Beijing, China | 5 | 1% | ||
| 7 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 4 | 1% | ||
| 8 | K2VC | Angel group | Beijing, China | 4 | 1% | ||
| 9 | 5Y Capital | Venture capital firm | Xuhui, China | 3 | 1% | ||
| 10 | BioVenture | Venture capital firm | Suzhou, China | 3 | 1% | ||
| 11 | Northern Light Venture Capital | Venture capital firm | Beijing, China | 3 | 1% | ||
| 12 | Legend Star | Venture capital firm | Beijing, China | 3 | 1% | ||
| 13 | Zhongguancun Science City Science | Venture capital firm | Haidian, China | 3 | 1% | ||
| 14 | Sequoia Capital | Venture capital firm | Menlo Park, United States | 2 | 0% | ||
| 15 | Legend Capital | Venture capital firm | Beijing, China | 2 | 0% | 1 | Diyingjia Technology |
Table 3. Health care startups in Beijing, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups in Beijing, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Beijing, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 4 | 8% | $82.2M |
| September 2026 | 4 | 8% | $179.1M |
| August 2026 | 5 | 10% | $75.6M |
| July 2026 | 3 | 6% | $31.8M |
| June 2026 | 4 | 8% | $29.5M |
| May 2026 | 1 | 2% | |
| April 2026 | 5 | 10% | $1.5M |
| March 2026 | 4 | 8% | $36.1M |
| February 2026 | 6 | 12% | $28.1M |
| January 2026 | 6 | 12% | $28.6M |
| December 2025 | 5 | 10% | $79.8M |
| November 2025 | 2 | 4% |
Table 6. Health care startups in Beijing, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 42 | 9% | $492.5M |
| 2025 | 31 | 7% | $210.7M |
| 2024 | 17 | 4% | $211.3M |
| 2023 | 25 | 6% | $418.7M |
| 2022 | 32 | 7% | $552.2M |
| 2021 | 37 | 8% | $2.0B |
Table 7. Health care startups in Beijing, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 11 | 2% |
| 2020 to 2022 | 35 | 8% |
| 2015 to 2019 | 186 | 42% |
| 2010 to 2014 | 132 | 30% |
| Before 2010 | 76 | 17% |
Table 8. Health care startups in Beijing, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 44 | 12% |
| 11 to 50 | 135 | 37% |
| 51 to 100 | 62 | 17% |
| 101 to 250 | 67 | 18% |
| 251 to 500 | 29 | 8% |
| 501 to 1,000 | 10 | 3% |
| 1,001 to 5,000 | 16 | 4% |
| 5,001 to 10,000 | 3 | 1% |
| 10,001 or more | 1 | 0% |
Table 9. Health care startups in Beijing, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Beijing, China. On 16 November 2026 that is 449 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 11 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 449 rows: 128 have no round amount, 0 no city and 180 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Beijing, China are on the list?
- 449, in the file dated 16 November 2026. 49 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 449 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.